Anticoagulant protein S in COVID-19: low activity, and associated with outcome
Introduction. COVID-19 disease was associated with both thrombo-embolic events and in-situ thrombi formation in small vessels. Antiphospholipidic antibodies were found in some studies.
Saved in:
Main Authors: | Stoichitoiu Laura Elena (Author), Pinte Larisa (Author), Balea Marius Ioan (Author), Nedelcu Valentin (Author), Badea Camelia (Author), Baicus Cristian (Author) |
---|---|
Format: | Book |
Published: |
Sciendo,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eosinophilic pancreatitis versus pancreatitis associated with eosinophilic gastroenteritis - a systematic review regarding clinical features and diagnosis
by: Pinte Larisa, et al.
Published: (2019) -
Causes of eosinophilic ascites - A systematic review
by: Pinte Larisa, et al.
Published: (2019) -
Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report
by: Tulbă Delia, et al.
Published: (2018) -
Will imaging change the diagnosis and management of giant cell arteritis?
by: Chiriac Andra, et al.
Published: (2019) -
Hyper-inflammation after COVID-19 mARN vaccination: at the crossroads of multisystem inflammatory disease and adult-onset Still's disease. Does terminology matter?
by: Baicus Cristian, et al.
Published: (2022)